FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971427875> ?p ?o ?g. }

• W1971427875 endingPage "1166" @default.
• W1971427875 startingPage "1160" @default.
• W1971427875 abstract "ObjectiveVacuum-assisted closure (VAC) therapy without muscle flap coverage is our primary approach for graft preservation in early, deep groin infections with and without exposed grafts; however, concerns exist regarding its safety. We report our experience in a consecutive series of patients with early groin infections managed without muscle flap closure.MethodsAll patients with early (<30 day), deep vascular groin infections without (Szilagyi II) or with (Szilagyi III) exposed vascular graft or suture line between January 2004 and December 2008 were reviewed. Graft preservation followed by local wound care with VAC was attempted in all with intact anastomoses, patent grafts, and absence of systemic sepsis. Szilagyi classification, microorganism cultured, duration of VAC use, time to healing, additional interventions, and follow-up data (limb salvage, survival) were analyzed.ResultsTwenty-two patients (26 groins, mean age 69.1 ± 9.5 years [range, 44-86 years]) presented with deep groin infections 16 ± 5 days (range, 7-28 days) after the index procedure (bypass-polytetrafluoroethylene [n = 11], autologous vein [n = 3], endarterectomy/patch [n = 6], extra-anatomic bypass [n = 5], percutaneous closure device [n = 1]). Grafts were exposed in 12 groins (Szilagyi III, nine with suture lines). VAC was started one to six days (median, three) after operative debridement. All had positive wound cultures and received culture-directed antibiotic therapy for 47 ± 45 days (range, 14-180 days). Length of stay was significantly more in Szilagyi III, whereas mean VAC use and time-to-healing were similar. Mean follow-up was 33.4 ± 19.5 months (range, 2-72 months). All wounds healed (mean, 49 ± 21 days). Two treatment failures occurred in the Szilagyi III group (17%). One patient had bleeding from the anastomotic heel eight days after debridement, had graft removal/in situ replacement and one presented with reinfection on day 117 and had partial graft removal/extra-anatomic bypass. There was no perioperative mortality or limb loss, but six late unrelated mortalities and one amputation at 46 months unrelated to the groin infection.ConclusionsManagement of early, deep groin wound infections with debridement, antibiotics, and VAC treatment is safe and enables graft preservation in the majority of patients with minimal morbidity, no perioperative limb loss, or mortality. Vacuum-assisted closure (VAC) therapy without muscle flap coverage is our primary approach for graft preservation in early, deep groin infections with and without exposed grafts; however, concerns exist regarding its safety. We report our experience in a consecutive series of patients with early groin infections managed without muscle flap closure. All patients with early (<30 day), deep vascular groin infections without (Szilagyi II) or with (Szilagyi III) exposed vascular graft or suture line between January 2004 and December 2008 were reviewed. Graft preservation followed by local wound care with VAC was attempted in all with intact anastomoses, patent grafts, and absence of systemic sepsis. Szilagyi classification, microorganism cultured, duration of VAC use, time to healing, additional interventions, and follow-up data (limb salvage, survival) were analyzed. Twenty-two patients (26 groins, mean age 69.1 ± 9.5 years [range, 44-86 years]) presented with deep groin infections 16 ± 5 days (range, 7-28 days) after the index procedure (bypass-polytetrafluoroethylene [n = 11], autologous vein [n = 3], endarterectomy/patch [n = 6], extra-anatomic bypass [n = 5], percutaneous closure device [n = 1]). Grafts were exposed in 12 groins (Szilagyi III, nine with suture lines). VAC was started one to six days (median, three) after operative debridement. All had positive wound cultures and received culture-directed antibiotic therapy for 47 ± 45 days (range, 14-180 days). Length of stay was significantly more in Szilagyi III, whereas mean VAC use and time-to-healing were similar. Mean follow-up was 33.4 ± 19.5 months (range, 2-72 months). All wounds healed (mean, 49 ± 21 days). Two treatment failures occurred in the Szilagyi III group (17%). One patient had bleeding from the anastomotic heel eight days after debridement, had graft removal/in situ replacement and one presented with reinfection on day 117 and had partial graft removal/extra-anatomic bypass. There was no perioperative mortality or limb loss, but six late unrelated mortalities and one amputation at 46 months unrelated to the groin infection. Management of early, deep groin wound infections with debridement, antibiotics, and VAC treatment is safe and enables graft preservation in the majority of patients with minimal morbidity, no perioperative limb loss, or mortality." @default.
• W1971427875 created "2016-06-24" @default.
• W1971427875 creator A5035842829 @default.
• W1971427875 creator A5039462912 @default.
• W1971427875 creator A5055020285 @default.
• W1971427875 creator A5060528338 @default.
• W1971427875 creator A5062648301 @default.
• W1971427875 creator A5088062648 @default.
• W1971427875 date "2010-05-01" @default.
• W1971427875 modified "2023-09-24" @default.
• W1971427875 title "Management of early (<30 day) vascular groin infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive patient series" @default.
• W1971427875 cites W170990964 @default.
• W1971427875 cites W1968579196 @default.
• W1971427875 cites W1970325179 @default.
• W1971427875 cites W1979305733 @default.
• W1971427875 cites W1985001683 @default.
• W1971427875 cites W1991182023 @default.
• W1971427875 cites W1991186905 @default.
• W1971427875 cites W2001508617 @default.
• W1971427875 cites W2020494061 @default.
• W1971427875 cites W2029708505 @default.
• W1971427875 cites W2033931022 @default.
• W1971427875 cites W2037314078 @default.
• W1971427875 cites W2039707045 @default.
• W1971427875 cites W2045054503 @default.
• W1971427875 cites W2049531438 @default.
• W1971427875 cites W2050121229 @default.
• W1971427875 cites W2051232127 @default.
• W1971427875 cites W2080645013 @default.
• W1971427875 cites W2081148339 @default.
• W1971427875 cites W2086760515 @default.
• W1971427875 cites W2091621323 @default.
• W1971427875 cites W2092083651 @default.
• W1971427875 cites W2130143418 @default.
• W1971427875 cites W2158049299 @default.
• W1971427875 cites W2164270009 @default.
• W1971427875 doi "https://doi.org/10.1016/j.jvs.2009.11.053" @default.
• W1971427875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20356703" @default.
• W1971427875 hasPublicationYear "2010" @default.
• W1971427875 type Work @default.
• W1971427875 sameAs 1971427875 @default.
• W1971427875 citedByCount "91" @default.
• W1971427875 countsByYear W19714278752012 @default.
• W1971427875 countsByYear W19714278752013 @default.
• W1971427875 countsByYear W19714278752014 @default.
• W1971427875 countsByYear W19714278752015 @default.
• W1971427875 countsByYear W19714278752016 @default.
• W1971427875 countsByYear W19714278752017 @default.
• W1971427875 countsByYear W19714278752018 @default.
• W1971427875 countsByYear W19714278752019 @default.
• W1971427875 countsByYear W19714278752020 @default.
• W1971427875 countsByYear W19714278752021 @default.
• W1971427875 countsByYear W19714278752022 @default.
• W1971427875 crossrefType "journal-article" @default.
• W1971427875 hasAuthorship W1971427875A5035842829 @default.
• W1971427875 hasAuthorship W1971427875A5039462912 @default.
• W1971427875 hasAuthorship W1971427875A5055020285 @default.
• W1971427875 hasAuthorship W1971427875A5060528338 @default.
• W1971427875 hasAuthorship W1971427875A5062648301 @default.
• W1971427875 hasAuthorship W1971427875A5088062648 @default.
• W1971427875 hasBestOaLocation W19714278751 @default.
• W1971427875 hasConcept C141071460 @default.
• W1971427875 hasConcept C2776204877 @default.
• W1971427875 hasConcept C2777202286 @default.
• W1971427875 hasConcept C2777327002 @default.
• W1971427875 hasConcept C2779967601 @default.
• W1971427875 hasConcept C71924100 @default.
• W1971427875 hasConcept C8443397 @default.
• W1971427875 hasConceptScore W1971427875C141071460 @default.
• W1971427875 hasConceptScore W1971427875C2776204877 @default.
• W1971427875 hasConceptScore W1971427875C2777202286 @default.
• W1971427875 hasConceptScore W1971427875C2777327002 @default.
• W1971427875 hasConceptScore W1971427875C2779967601 @default.
• W1971427875 hasConceptScore W1971427875C71924100 @default.
• W1971427875 hasConceptScore W1971427875C8443397 @default.
• W1971427875 hasIssue "5" @default.
• W1971427875 hasLocation W19714278751 @default.
• W1971427875 hasLocation W19714278752 @default.
• W1971427875 hasOpenAccess W1971427875 @default.
• W1971427875 hasPrimaryLocation W19714278751 @default.
• W1971427875 hasRelatedWork W1974300621 @default.
• W1971427875 hasRelatedWork W2018144414 @default.
• W1971427875 hasRelatedWork W2042472674 @default.
• W1971427875 hasRelatedWork W2132079435 @default.
• W1971427875 hasRelatedWork W2413486660 @default.
• W1971427875 hasRelatedWork W2417536767 @default.
• W1971427875 hasRelatedWork W2434140900 @default.
• W1971427875 hasRelatedWork W2977406693 @default.
• W1971427875 hasRelatedWork W4301489211 @default.
• W1971427875 hasRelatedWork W2967382458 @default.
• W1971427875 hasVolume "51" @default.
• W1971427875 isParatext "false" @default.
• W1971427875 isRetracted "false" @default.
• W1971427875 magId "1971427875" @default.
• W1971427875 workType "article" @default.